Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Dorward, S ^b   Sreedharan, Aravamuthan ^a   Leontiadis, G I ^b   Howden, C W ^b   Moayyedi, P ^b   Forman, D ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; TRANEXAMIC ACID;

ADULT; BLOOD TRANSFUSION; CINAHL; COCHRANE LIBRARY; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DIAGNOSTIC PROCEDURE; EMBASE; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SURGERY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MALE; MEDLINE; MORTALITY; QUANTITATIVE ANALYSIS; REVIEW; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING;

EID: 42749098839     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005415.pub2     Document Type: Review

References (71)

1. Daneshmand TK, Hawkey CJ, Langman MJ, Logan RG, Walt RP. Omperpazole versus placebo for acute upper gastrointestinal bleeding: Randomised double blind controlled trial. BMJ 1992;304:143-7.
2. Hawkey GM, Cole AT, McIntyre AS, Long RG, Hawkey CJ. Drug Treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points. Gut 2001;49:372-9.
3. Hulagu S, Demirturk L, Gul S, Yazgan Y, Altin M, Danaci M. The effect of omeprazole or ranitidine intravenous on upper gastrointestinal bleeding. Endoskopi Journal 1995;2:35-43.
4. Lau JY, Leung WK, Wu JC, Chan FK, Wong V, Hung LC, Cheung K, Yung M, Lee VW, Chiu PW, Ng EK, Lee KK, Sung JJ. Early administration of high dose intravenous omeprazole prior to endoscopy in patients with upper gastrointestinal bleeding: A double blind placebo controlled randomized trial. Gastroenterology. 2005; Vol. 128 (suppl 4), issue Suppl 4:A 347.
5. Wallner G, Ciechanski A, Wesolowski M, Sory A, Misiuna P. Treatment of acute upper gastrointestinal bleeding with intravenous omeprazole or ranitidine. European Journal of Clinical Research 1996;8:235-43.
6. Bai G, Hu FL, Lu DH, Qin J. Efficacy of intravenous administration of omeprazole in the treatment of upper gastrointestinal haemorrhage caused by peptic ulcer and acute gastric mucosal lesion. The Chinese Journal of Clinical Pharmacology 1995;11:206-209.
7. Chu XQ, Jia LS. Effects of omeprazole and ranitidine on the treatment of peptic ulcer hemorrhage. Journal of Gastroenterology and Hepatology 1993;8(Suppl 2):S239.
8. Colin R, Michel P, Sallerin V. Comparison of the efficacy of lansoprazole and ranitidine in the prevention of early relapse in people with upper gastrointestinal uclerative haemorrhage with a high risk of early recurrence of rebleeding. A double blind multi centre study. Gastroenterolgie Clinique et Biologique 1993;17:A105.
9. Costamagna G, Mutignani M, Perri V, Colombo GM, Bruni A, Gabbrielli A, D Pietro C, Cruciiti F. Lansoprazole in preventing bleeding relapse in upper gastointestinal non variceal bleeding. Gatroenterology 1998;114(Suppl.):A95.
10. Dovas A. Medical treatment of active bleeding of upper gastointestinal tract: Omeprazole or H2 antagonists? A comparative study. Annales Medicales 1992:169-72.
11. Fasseas P, Leybishkis B, Rocca G. Omeprazole versus ranitidine in the medical treatment of acute upper gastrointestinal bleeding: assessment by repeat early endoscopy. International Journal of Clinical Practice 2001;55:661-4.
12. Felder LR, Barkin JS. A comparison of omeprazole and placebo for bleeding peptic ulcer. Gastrointestinal Endoscopy 1998;47(5):428-9.
13. Fried R, Beglinger C, Meier R, Stumpf J, Adler G, Schepp W, Klein M, Fischer R. Comparison on intravenous Pantoprazole with intravenous ranitidine in peptic ulcer bleeding. Gut 1999;45(Suppl V):A100.
14. Gao Z, Deng C, Yi J. The effect of omeprazole on upper gastrointestinal haemorrhage. Acta Academaie Medicinae Hubei 1995;16:223-5.
15. Goletti O, Sidoti F, Lippolis PV, De Negri F, Cavina E. Omeprazole versus ranitidine plus somatostatin in the treatment of severe gastroduodenal bleeding: A prospective, randomised controlled trial. Italian Journal of Gastroenterology 1994;26:72-4.
16. Hulagu S, Demirturk L, Gul S, Yazgan Y, Altin M, Danaci M. The effect of omeprazole or ranitidine intravenous on upper gastrointestinal bleeding. Endoscopy 1994;26:404.
17. Liu RH, Wei CM, Wang XP, Yin ZZ. The efficacy of Losec versus famotidine in the treatment of bleeding duodenal ulcer. Shanghai Medical and Pharmaceutical Journal 2002;23(7):199-201.
18. Maculotti L, Pradella P. Comparison between ranitidine, famotidine and omeprazole in the treatment of bleeding duodenal ulcer. Minerva Chirurgica 1995;50(3):279-81.
19. Munkel L, French L. Treatment of bleeding peptic ulcers with omeprazole. Journal of Family Practice 1997;45(1):20-1.
20. Nehme O, Barkin JS. Recurrent ulcer bleeding: Is intravenous omeprazole the solution. American journal of Gastroenterology 2001;96(2):594- 5.
21. Orti E, Canelles P, Quiles F, Zapater R, Cuquerella J, Ariete V, Tome A, Medina E. Is upper gastrointestinal bleeding evolution influenced by the used antisecretory. Revista Espanola De Enfermedades Digestivas 1995;87:427-30.
22. Savides TJ, Pratha V. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. Gastrointestinal Endoscopy 2001;54(1):130-2.
23. Scheurlen M. Peptic ulcer hemorrhage: IV antacid prevents recurrence. Fortschritte der Medzin 2000;142(45):30.
24. Schonekas H, Ahrens H, Pannewick U, Ell C, Koop H, Petritsch W, Klein M, Fischer R. Comparison of two doses of intravenous pantoprazole in peptic ulcer bleeding. Gut 1999;45(Suppl V):A104.
25. Srinath C. Comparison of omeprazole and placebo for bleeding peptic ulcer. Tropical Gastroenterology 1997;18(3):115-6.
26. Udd M, Miettinen P, Janatuinen E, Heikkinen M, Tarvainen R, Pasanen P, et al. Regular versus high dose omeprazole for peptic ulcer bleeding - prospective randomised double blind study. Annales Chirurgiae et Gynaecologiae 1999;88(2):169.
27. Uribarrena R, Bajador E, Simon MA, Sebastian JJ, Gomollon F. Omeprazole and cimetidine in the treatment of upper disgestive haemorrhage. Revista Espanola de Enfermedades Digestivas 1994;86:878-83.
28. Wu N, Wang SJ, Wang SG, Pan GH. Therapeutic efficacy of pantoprazole on upper gastrointestinal hemorrhage. Chinese New Medicine 2001;2(12):1091-2.
29. Xuan JL. Loseco compared with famotisine in the treatment of upper gastrointestinal bleeding: clinical analysis of 90 cases. Guangxi Medical Journal 2003;25:529-31.
30. Andrews C, Zandieh I, Brodie M. Appropriateness of discontinuation of intravenous proton pump inhibitor (IV PPI) in bleeding peptic ulcer patients without high risk ulcer stigmata at endoscopy: preliminary results of multicenter evaluation. Gastrointestinal Endoscopy 2002;55(5): A592.
31. Andrews C, Zandieh I, Levy AR. Comparison of intravenous proton pump inhibitor (IV PPI) use between hospitals:preliminary results. Gastrointestinal Endoscopy 2002;55(5):T1874.
32. Andriulli A, Annese V, Caruso N, Pilotto A, Accadia L, Niro AG, Quitadamo M, Merla A, Fiorella S, Leandro G. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses. American Journal of Gastroenterology 2005;100(9):2133.
33. Bardou M, Toubouti Y. Benhaberou-Brun D, Rahme E, Barkun AN. Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding. Alimentary Pharmacology and Therapeutics 2005;21:677-86.
34. Barkun AN, Bardou M, Marshall JK. Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding Conference Group. Annals of Internal Medicine 2003;169:843-57.
35. Barkun A N, Herba K, Adam V, Kenedy W, Fallone C A, Bardou M. High dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcer in the USA and Canada : A Cost-effective analysis. Aliment Pharmacol and Ther 2004;19:591- 600.
36. Barkun A, Bardou M. The role of PPI therapy in upper GI tract bleeding. Gastroenterology and Hepatology Annual Review 2006; Vol. 1:20-4.
37. Blatchford O, Davidson LA, Murray WR, Blatchford M, Pell J. Acute upper gastrointestinal haemmorrhage in west of Scotland: A case ascertainment study. BMJ 1997;315:510-4.
38. Brunner G, Chang J. Intravenous therapy with high doses of ranitidine and omeprazole in criticaly ill patients with bleeding peptic ulcerations of the upper intestinal tract: An open randomised controlled trial. Digestion 1990;45(4):217-25.
39. Brunner G, Luna P, Hartman M, Wurst W. Optimising the intra gastric PH as supportive therapy in upper GI bleeding. Yale J Biol Med 1996;69:225-31.
40. Enns RA, Gagnon YM, Rioux KP, Levy AR. Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding. Alimentary Pharmacology and Therapeutics 2003;17:225-233.
41. Gagnon YM, Levy AR, Eloubeidi MA. Cost implications of administering intravenous proton pump inhibitors to all patients presenting to the emergency department with peptic ulcer bleeding. Value Health 2003;6:457-65.
42. Gilbert DA. Epidemiology of upper gastrointestinal bleeding. Gastrointestinal Endoscopy 1990;36:S8-13.
43. Gisbert JP, Gonzalez L, Calvet X, Roque M, Gabriel R, Pajares JM. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer. Alimentaryt Pharmacology and Therapeutics 2001;15(7):917-26.
44. Gralnek IM, Jensen DM, Kovacs TP. An economic analysis of patients with active arterial peptic ulcer hemorrhage treated with endoscopic heater probe, injection sclerosis or surgery in a prospective randomised trial. Gastrointestinal Endoscopy 1997;46:105-12.
45. Gralnek IM, Jensen DM, Gornbein J. Clinical and economic outcomes of individuals with severe peptic ulcer hemorrhage and non-bleeding visible vessel: An analysis of two prospective clinical trials. American Journal of Gastroenterology 1998;93:2047-56.
46. Green FW, Kaplan MM, Curtis LE. Effect of acid and pepsin on blood coagulation and platelet aggregation: A possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978;74(Suppl 1):38-43.
47. Hasselgren G. Optimisation of acid suppression for patients with peptic ulcer bleeding. An intra gastric PH-metry study with omeprazole. Eur J Gastroenterol Hepatol 1998;10:601-6.
48. Higham J, Kang JY, Majeed A. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects. Gut 2002;50:460-4.
49. Jiranek GC, Kozarek RA. A cost effective approach to the patient with peptic ulcer bleeding. Surgery Clinics of North America 1996;76:83-103.
50. Khuroo MS, Khuroo MS, Farahat KL, Kagevi IE. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis. Journal of Gastroenterology and Hepatology 2005;20:11-25.
51. Kolkman JJ, Meuwissen SGM. A review on treatment of bleeding peptic ulcer. A collaborative task of gastroenterologist and surgeon. Scan J Gasteroenterol 1996;31(Suppl 218):16-25.
52. Laine L, Peterson WL. Bleeding peptic ulcer. New Eng J Med 1994;331:717-27.
53. Lau JY, Chung SCS, Leung JW, Lo KK, Yung Y, Li AKC. The evoluation of stigmata of hemorrhage in bleeding peptic ulcers: A sequential endoscopic study. Endoscopy 1998;30(6):513-518.
54. Lee JG, Turnipseed S, Romano PS. Endoscopy based triage significantly reduces hospitalisation rates and costs of treating upper GI bleeding: A randomised controlled trial. Gastrointestinal Endoscopy 1999;50:755-61.
55. Lee KK, You JH, Wong IC. Cost-effectiveness analysis of high-dose omeprazole infusion as adjuvant therapy to endoscopic treatment of bleeding peptic ulcer. Gastrointestinal Endoscopy 2003;57:160-4.
56. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding (Cochrane Review). In: The Cochrane Library, 1, 2006. John Wiley & Sons, Ltd..
57. Longstreth GF, Feitelberg SP. Outpatient care of selected patients with acute non-variceal upper gastrointestinal haemorrhage. Lancet 1995;345:108-11.
58. Longstreth GF. Epidemiology and outcome of patients hospitalized with. American Journal Gastroenterology 1997;92:419-24.
59. Low J, Dodds AJ, Biggs JC. Fibrinolytic activity of gastroduodenal secretions-a possible role in upper gastrointestinal haemorrhage. Thrombosis Research 1980;17:819-30.
60. Naumovski-Mihalic S, Katicic M, Colic-Cvlje V, Bozek T, Prskalo M, Sabaric B, et al. Intravenous proton pump inhibitor in ulcer bleeding in patients admitted to an intensive care unit. Gastroenterology 2005;128 suppl 4:W1578.
61. Paimela H, Paimela R, Luosujarvi E. Kivilaakso E. Current features of peptic ulcer disease in Finland. Incidence of surgery, hospital admissions and mortality for the disease during the past twenty- five years. Scandanavian Journal of Gastroenterology 2002;37:399-403.
62. Palmer. Non-variceal upper gastrointestinal haemorrhage: guidelines. British Society of Gastroenterology Endoscopy Committee. Gut 2002;51(Suppl 4):1-6.
63. Perez Flores R, Garcia Molinero MJ, Herrero Quiros C, Blasco Colmenarejo MM, Caneiro Alcubilla E, Garcia-Rayo Somoza M, Cabot Lozano A. The treatment of upper digestive hemorrhage of peptic origin: intravenous ranitidine versus intravenous omeprazole. Rev Esp Enferm Dig 1994;86(3):637-41.
64. Rockall TA, Logan RFA, Devlin HB, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. BMJ 1995;311:222-6.
65. Selby NM, Kubba AK, Hawkey CJ. Acid suppression in peptic ulcer haemorrhage: a 'meta-analysis'. Alimentary Pharmacology and Therapeutics 2000;14(9):1119-26.
66. Silverstein FE, Gilbert DA, Tedesco FJ, Buenger NK, Persing J. The national ASGE survey on upper gastrointestinal bleeding. I. Study design and baseline data. Gastrointestinal Endoscopy 1981;27(2):73-9.
67. Spiegel BM, Ofman JJ, Woods K, Vakil NB. Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategies. American Journal of Gastroenterology 2003;98:86-97.
68. Sung JY, Chan FK, Lau JWW. The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with non bleeding visible vessels or adherent clots: A randomised comparison. Ann Intern Med 2003;139:237-43.
69. van Leerdam ME, Vreeburg EM, Rauws EAJ, Geraedts AM, Tijssen JGP, Reitsma JB, Tytgat GNJ. Acute upper GI bleeding: Did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. American Journal of Gastroenterology 2003;98:1494-9.
70. Van Rensburg CJ, Hartman M, Thorpe A. Intragastric PH during continuous infusion with Pantoprazole in patients with bleeding peptic ulcer. Am J Gastroenterol 2003;98:2635-41.
71. Zandieh I, Andrews C, Brodie M. Prescribing practices and indications for the use of intravenous proton pump inhibitors (IV PPI) in six urban tertiary care centres. Gastrointestinal Endoscopy 2002;55(5):T1883.